STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.
<p>Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.</p>